The DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index.
Tumors and inflammatory infiltrates: Friends or foes?
Abstract
The recognition of a role for inflammation in the natural history of a tumor has a long record, stretching from the mid-19th century. From the times of Virkow, who postulated that cancer originates from inflamed tissues, to Metchnikoff and many others, this field has continued to excite (and divide) the scientific community. The question as to whether the inflammatory infiltrate helps or hinders tumors is still open. In a sense, modern molecular biology has, if anything, worsened this dualism, and the literature on this issue shows a plethora of conflicting reports. We would like to provide another contribution to this topic, which was the subject of a recent brilliant review (Balkwill F and Mantovani A. Lancet 2001; 357: 539-45), by focussing more specifically to the relation between inflammation and tumor invasion and how this could drive rational therapeutic approaches.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TAMs have a dual role in neoplasms — although they may kill neoplastic cells following activation by IL-2, interferon and IL-12 (refs 15, 16), TAMs produce a number of potent angiogenic and lymphangiogenic growth factors, cytokines and proteases, all of which are mediators that potentiate neoplastic progression17.”
From Inflammation and cancer (2002) · cites this paper as [15]
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Sallusto, F., & Lanzavecchia, A. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.4.1109 · Cited by 5,129
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W. W., Fong, H. H. S., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., et al. (1997) · Science · doi:10.1126/science.275.5297.218 · Cited by 4,935 · cited 1×
“ATP synthase-inhibitors, such as Piceatannol [67] and Resveratrol [68] are effective inhibitors of tumor growth.”
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines.
Baggiolini, M., Dewald, B., & Moser, B. (1994) · PubMed · Cited by 2,232
Rollins, B. J. (1997) · Blood · doi:10.1182/blood.v90.3.909.909_909_928 · Cited by 2,126
Ulcerative Colitis and Colorectal Cancer
Ekbom, A., Helmick, C. G., Zack, M. M., & Adami, H. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011013231802 · Cited by 1,794
The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract
Tachibana, K., Hirota, S., Iizasa, H., Yoshida, H., Kawabata, K., Kataoka, Y., Kitamura, Y., Matsushima, K., Yoshida, N., Nishikawa, S.-I., et al. (1998) · Nature · doi:10.1038/31261 · Cited by 1,547
Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
Tsujii, M., Kawano, S., & DuBois, R. N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3336 · Cited by 1,398
MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis
Coussens, L. M., Tinkle, C. L., Hanahan, D., & Werb, Z. (2000) · Cell · doi:10.1016/s0092-8674(00)00139-2 · Cited by 1,306
A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening
Chen, Y., Scanlan, M. J., Şahin, U., Türeci, Ö., Gure, A. O., Tsang, S., Williamson, B., Stockert, E., Pfreundschuh, M. G., & Old, L. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1914 · Cited by 1,247
The origin and function of tumor-associated macrophages
Mantovani, A., Bottazzi, B., Colotta, F., Sozzani, S., & Ruco, L. P. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90008-u · Cited by 1,088
PPARδ Is an APC-Regulated Target of Nonsteroidal Anti-Inflammatory Drugs
He, T., Chan, T. A.-T., Vogelstein, B., & Kinzler, K. W. (1999) · Cell · doi:10.1016/s0092-8674(00)81664-5 · Cited by 1,083
Salcedo, R., Ponce, M. L., Young, H. A., Wasserman, K., Ward, J. M., Kleinman, H. K., Oppenheim, J. J., & Murphy, W. J. (2000) · Blood · doi:10.1182/blood.v96.1.34 · Cited by 860
Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis
Moore, R. J., Owens, D. M., Stamp, G., Arnott, C., Burke, F., East, N., Holdsworth, H., Turner, L., Rollins, B., Pasparakis, M., et al. (1999) · Nature Medicine · doi:10.1038/10552 · Cited by 839
Jones, M. K., Wang, H., Peskar, B. M., Levin, E. R., Itani, R. M., Sarfeh, I. J., & Tarnawski, A. S. (1999) · Nature Medicine · doi:10.1038/70995 · Cited by 826
Transforming growth factor-beta: recent progress and new challenges.
Sporn, M. B., & Roberts, A. B. (1992) · The Journal of Cell Biology · doi:10.1083/jcb.119.5.1017 · Cited by 760
Richard, D. E., Berra, E., & Pouysségur, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003325200 · Cited by 635
Alterations in Signal Transduction Molecules in T Lymphocytes from Tumor-Bearing Mice
Mizoguchi, H., O’Shea, J. J., Longo, D. L., Loeffler, C. M., McVicar, D. W., & Ochoa, A. C. (1992) · Science · doi:10.1126/science.1465616 · Cited by 632
Lefebvre, A., Chen, I., Desreumaux, P., Najïb, J., Fruchart, J., Geboes, K. J., Briggs, M., Heyman, R. A., & Auwerx, J. H. (1998) · Nature Medicine · doi:10.1038/2036 · Cited by 610
Addison, C., Daniel, T. O., Burdick, M. D., Liu, H., Ehlert, J. E., Xue, Y., Buechi, L., Walz, A., Richmond, A. J., & Strieter, R. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.9.5269 · Cited by 582
The biology of the 17–1A antigen (Ep-CAM)
Balzar, M., Winter, M. J., de Boer, C. J., & Litvinov, S. V. (1999) · Journal of Molecular Medicine · doi:10.1007/s001099900038 · Cited by 545
An overview of the MAGE gene family with the identification of all human members of the family.
Chomez, P., Backer, O. D., Bertrand, M. J. M., Plaen, E. D., Boon, T., & Lucas, S. (2001) · PubMed · Cited by 481
Moch, H., Gasser, T., Amin, M. B., Torhorst, J. K. H., Sauter, G., & Mihatsch, M. J. (2000) · Cancer · doi:10.1002/1097-0142(20000801)89:3 · Cited by 472
Effects of Thalidomide and Related Metabolites in a Mouse Corneal Model of Neovascularization
Kenyon, B. M., Browne, F., & D’Amato, R. J. (1997) · Experimental Eye Research · doi:10.1006/exer.1997.0292 · Cited by 436
The intriguing role of polymorphonuclear neutrophils in antitumor reactions
Di Carlo, E., Forni, G., Lollini, P., Colombo, M. P., Modesti, A., & Musiani, P. (2001) · Blood · doi:10.1182/blood.v97.2.339 · Cited by 419
Ulcerative colitis and colorectal cancer
Ekbom, A. (1991) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(91)90009-i · Cited by 419
Coughlin, C. M., Salhany, K. E., Wysocka, M., Aruga, E., Kurzawa, H., Chang, A. E., Hunter, C. A., Fox, J. C., Trinchieri, G., & Lee, W. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1555 · Cited by 415
TNF-alpha and IL-1beta selectively induce expression of 92-kDa gelatinase by human macrophages
Sarén, P., Welgus, H. G., & Kovanen, P. T. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.9.4159 · Cited by 407
Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration
Wada, Y., Nakashima, O., Kutami, R., Yamamoto, O., & Kojiro, M. (1998) · Hepatology · doi:10.1002/hep.510270214 · Cited by 405
Romagnani, P., Annunziato, F., Lasagni, L., Lazzeri, E., Beltrame, C., Francalanci, M., Uguccioni, M., Galli, G., Cosmi, L., Maurenzig, L., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci9775 · Cited by 377
Porgador, A., & Gilboa, E. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.1.255 · Cited by 373
Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma.
Smith, D. R., Polverini, P. J., Kunkel, S. L., Orringer, M. B., Whyte, R. I., Burdick, M. D., Wilke, C. A., & Strieter, R. M. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.5.1409 · Cited by 368
Elder, D. J. E., Halton, D. E., Hague, A., & Paraskeva, C. (1997) · PubMed · Cited by 366
Regulation of the Macrophage Content of Neoplasms by Chemoattractants
Bottazzi, B., Polentarutti, N., Acero, R., Balsari, A., Boraschi, D., Ghezzi, P., Salmona, M., & Mantovani, A. (1983) · Science · doi:10.1126/science.6828888 · Cited by 352
Eisen, T. G., Boshoff, C., Mak, I., Sapunar, F. J., Vaughan, M., Pyle, L. M., Johnston, S. R. D., A’Hern, R., Smith, I. E., & Gore, M. E. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1004 · Cited by 336
‘Angioprevention’: angiogenesis is a common and key target for cancer chemopreventive agents
Tosetti, F., Ferrari, N., Flora, S. D., & Albini, A. (2002) · The FASEB Journal · doi:10.1096/fj.01-0300rev · Cited by 325
Self-citationGasperini, S., Marchi, M., Calzetti, F., Laudanna, C., Vicentini, L. M., Olsen, H. S., Murphy, M., Liao, F., Farber, J. M., & Cassatella, M. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.8.4928 · Cited by 314
Potent inhibitory action of red wine polyphenols on human breast cancer cells
Damianaki, A., Bakogeorgou, E., Kampa, M., Notas, G., Hatzoglou, A., Panagiotou, S., Gemetzi, C., Kouroumalis, E., Martin, P., & Castanas, E. (2000) · Journal of Cellular Biochemistry · doi:10.1002/1097-4644(20000901)78:3 · Cited by 314
Gasperini, S., Marchi, M., Calzetti, F., Laudanna, C., Vicentini, L. M., Olsen, H., Murphy, M., Liao, F., Farber, J. M., & Cassatella, M. A. (1999) · PubMed · Cited by 304
Elevated cyclooxygenase-2 levels in Min mouse adenomas
Williams, C. S., Luongo, C., Radhika, A., Zhang, T., Lamps, L. W., Nanney, L., Beauchamp, R. D., & Dubois, R. N. (1996) · Gastroenterology · doi:10.1016/s0016-5085(96)70083-5 · Cited by 302
Tannenbaum, C. S., Tubbs, R., Armstrong, D., Finke, J. H., Bukowski, R. M., & Hamilton, T. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.2.927 · Cited by 295
Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells.
Jonjić, N., Peri, G., Bernasconi, S., Sciacca, F. L., Colotta, F., Pelicci, P., Lanfrancone, L., & Mantovani, A. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.4.1165 · Cited by 290
Clinical trials of antibody therapy
Glennie, M. J., & Johnson, P. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01669-8 · Cited by 290
Expression and regulation of chemokine receptors in human natural killer cells
Inngjerdingen, M., Damaj, B. B., & Maghazachi, A. A. (2001) · Blood · doi:10.1182/blood.v97.2.367 · Cited by 287
Roboz, G. J., Dias, S., Lam, G. F. M., Lane, W. J., Soignet, S. L., Warrell, R. P., & Rafii, S. (2000) · Blood · doi:10.1182/blood.v96.4.1525 · Cited by 275
Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies
Darnell, R. B., & DeAngelis, L. M. (1993) · The Lancet · doi:10.1016/0140-6736(93)92485-c · Cited by 259
Role of Interleukin-8 in Tumor Growth and Metastasis of Human Melanoma
Bar‐Eli, M. (1999) · Pathobiology · doi:10.1159/000028045 · Cited by 248
Mingari, M. C., Moretta, A., & Moretta, L. (1998) · Immunology Today · doi:10.1016/s0167-5699(97)01236-x · Cited by 244
Total parenteral nutrition and cancer clinical trials
Klein, S., Simes, R. J., & Blackburn, G. L. (1986) · Cancer · doi:10.1002/1097-0142(19860915)58:6 · Cited by 243
Nesbit, M., Schaider, H., Miller, T. H., & Herlyn, M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6483 · Cited by 235
Ahmad, N., Gupta, S., Husain, M. M., Heiskanen, K. M., & Mukhtar, H. (2000) · PubMed · Cited by 224
Inobe, J.-I., Slavin, A., Komagata, Y., Chen, Y., Liu, L., & Weiner, H. L. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199809)28:09 · Cited by 214
Combined chemokine and cytokine gene transfer enhances antitumor immunity
Dilloo, D., Bacon, K. B., Holden, W. T., Zhong, W., Burdach, S. E. G., Zlotnik, A., & Brenner, M. K. (1996) · Nature Medicine · doi:10.1038/nm1096-1090 · Cited by 207
Luan, J. Y., Shattuck-Brandt, R. L., Haghnegahdar, H., Owen, J. D., Strieter, R. M., Burdick, M. D., Nirodi, C. S., Beauchamp, D., Johnson, K. N., & Richmond, A. J. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.62.5.588 · Cited by 205
Mantovani, A. (1994) · PubMed · Cited by 204
Proost, P., Wolf‐Peeters, C. D., Conings, R., Opdenakker, G., Billiau, A., & Damme, J. V. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.3.1000 · Cited by 196
Delayed Wound Healing in Immunodeficient TGF-β1 Knockout Mice
Crowe, M. J., Doetschman, T., & Greenhalgh, D. G. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00010.x · Cited by 194
Extracellular ATP and TNF-α Synergize in the Activation and Maturation of Human Dendritic Cells
Schnurr, M. M., Then, F., Galambos, P., Scholz, C., Siegmund, B., Endres, S., & Eigler, A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.8.4704 · Cited by 194
Benelli, R., Morini, M., Carrozzino, F., Ferrari, N., Minghelli, S., Santi, L., Cassatella, M. A., Noonan, D. M., & Albini, A. (2001) · The FASEB Journal · doi:10.1096/fj.01-0651fje · Cited by 188
Self-citationBaselga, J. M. (2001) · Oncology · doi:10.1159/000055397 · Cited by 179
Chan, M. M.-Y., Mattiacci, J. A., Hwang, H. S., Shah, A., & Fong, D. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00471-8 · Cited by 175
Tumor invasion: molecular shears blunted by green tea
Garbisa, S., Biggin, S., Cavallarin, N., Sartor, L., Benelli, R., & Albini, A. (1999) · Nature Medicine · doi:10.1038/15145 · Cited by 174
Self-citationFeil, C., & Augustin, H. G. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8499 · Cited by 172
Two stages of cancer prevention with green tea
Fujiki, H. (1999) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320050321 · Cited by 168
PML nuclear bodies are general targets for inflammation and cell proliferation.
Terris, B., Baldin, V., Dubois, S., Degott, C., Fléjou, J., Hénin, D., & Dejean, A. (1995) · PubMed · Cited by 163
Cytokines, tumour-cell death and immunogenicity: a question of choice
Musiani, P., Modesti, A., Giovarelli, M., Cavallo, F., Forni, G., Lollini, P., & Colombo, M. P. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)80012-6 · Cited by 162
Bussolati, B., Biancone, L., Cassoni, P., Russo, S., Rola‐Pleszczynski, M., Montrucchio, G., & Camussi, G. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64808-0 · Cited by 140
Induction of apoptosis by hydrolyzable tannins from Eugenia jambos L. on human leukemia cells
Yang, L. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00477-8 · Cited by 137
Induction of Functional IL-8 Receptors by IL-4 and IL-13 in Human Monocytes
Bonecchi, R., Facchetti, F., Dusi, S., Luini, W., Lissandrini, D., Simmelink, M. J. A., Locati, M., Bernasconi, S., Allavena, P., Brandt, E., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.7.3862 · Cited by 132
Guo, W., Lonardo, F., Ueda, T., Kim, T. K., Huvos, A. G., Healey, J. H., & Ladanyi, M. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990118)80:2 · Cited by 125
Martins‐Green, M. M., Boudreau, N. J., & Bissell, M. J. (1994) · PubMed · Cited by 120
Quantitative analysis of chemokine expression by dendritic cell subsets in vitro and in vivo
Vissers, J. L. M., Hartgers, F. C., Lindhout, E., Teunissen, M. B. M., Figdor, C. G., & Adema, G. J. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.5.785 · Cited by 120
Human neutrophils exhibit disparate chemotactic factor gene expression
Strieter, R. M., Kasahara, K., Allen, R., Showell, H. J., Standiford, T. J., & Kunkel, S. L. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80095-6 · Cited by 112
Review Article The immunology and immunotherapy of breast cancer: an update
Hadden, J. W. (1999) · International Journal of Immunopharmacology · doi:10.1016/s0192-0561(98)00077-0 · Cited by 107
Vukanovic, J., & Isaacs, J. T. (1995) · PubMed · Cited by 102
Fas/Fas Ligand Interaction in Human Colorectal Hepatic Metastases
Yoong, K. F., Afford, S. C., Randhawa, S., Hübscher, S. G., & Adams, D. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65316-3 · Cited by 101
Zheng, J., & Ramirez, V. D. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1063 · Cited by 100
James, N. D., Atherton, P. J., Jones, J. L., Howie, A. J., Tchekmedyian, S., & Curnow, R. T. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1878 · Cited by 100
Mortarini, R., Borri, A., Tragni, G., Bersani, I., Vegetti, C., Bajetta, E., Pilotti, S., Cerundolo, V., & Anichini, A. (2000) · PubMed · Cited by 98
Sciacca, F. L., Stürzl, M., Bussolino, F., Sironi, M., Brandstetter, H., Zietz, C., Zhou, D., Matteucci, C., Peri, G., Sozzani, S., et al. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.10.4816 · Cited by 96
Self-citationLi, M., Wu, X., & Xu, X. (2001) · PubMed · Cited by 96
IL-2 up-regulates but IFN-gamma suppresses IL-8 expression in human monocytes.
Gusella, G. L., Musso, T., Bosco, M. C., Espinoza‐Delgado, I., Matsushima, K., & Varesio, L. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.5.2725 · Cited by 94
Joshi, P. C., Zhou, X., Cuchens, M. A., & Jones, Q. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.885 · Cited by 94
Cytokine Expression and Release by Neutrophilsa
Cassatella, M. A., Gasperini, S., & Russo, M. P. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb46251.x · Cited by 90
Interleukin 1 alpha acts as an autocrine growth stimulator for human gastric carcinoma cells.
Ito, R., Kitadai, Y., Kyo, E., Yokozaki, H., Yasui, W., Yamashita, U., Nikai, H., & Tahara, E. (1993) · PubMed · Cited by 86
CIIV, MIIC and other compartments for MHC class II loading
Neefjes, J. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199905)29:05 · Cited by 84
IL-4 prevents the blockade of dendritic cell differentiation induced by tumor cells.
Ménétrier‐Caux, C., Thomachot, M. C., Alberti, L., Montmain, G., & Blay, J. (2001) · PubMed · Cited by 83
Colombo, N., Peccatori, F. A., Paganin, C., Bini, S., Brandely, M., Mangioni, C., Mantovani, A., & Allavena, P. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910510109 · Cited by 79
Carlo, E. D., Comes, A., Basso, S., Ambrosis, A. D., Meazza, R., Musiani, P., Moelling, K., Albini, A., & Ferrini, S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3111 · Cited by 75
Self-citationHuman Small Cell Lung Carcinoma and Carcinoid Tumor Regulate Dendritic Cell Maturation and Function
Katsenelson, N. S., Shurin, G. V., Быковская, С. Н., Shogan, J., & Shurin, M. R. (2001) · Modern Pathology · doi:10.1038/modpathol.3880254 · Cited by 74
Nakashima, E., Oya, A., Kubota, Y., Kanada, N., Matsushita, R., Takeda, K., Ichimura, F., Kuno, K., Mukaida, N., Hirose, K., et al. (1996) · Pharmaceutical Research · doi:10.1023/a:1016057830271 · Cited by 69
Capodici, C., Pillinger, M. H., HAN, G., Philips, M. R., & Weissmann, G. (1998) · Journal of Clinical Investigation · doi:10.1172/jci592 · Cited by 68
Ajoene, a natural product with non-steroidal anti-inflammatory drug (NSAID)-like properties?
Dirsch, V. M., & Vollmar, A. M. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00580-3 · Cited by 68
Iizuka, N., Miyamoto, K., Hazama, S., Yoshino, S., Yoshimura, K., Okita, K., Fukumoto, T., Yamamoto, S., Tangoku, A., & Oka, M. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00496-1 · Cited by 67
Benelli, R., Barbero, A., Ferrini, S., Scapini, P., Cassatella, M. A., Bussolino, F., Tacchetti, C., Noonan, D. M., & Albini, A. (2000) · The Journal of Infectious Diseases · doi:10.1086/317597 · Cited by 67
Self-citationCouriel, D. R., Hicks, K. L., Giralt, S. A., & Champlin, R. E. (2000) · Current Opinion in Oncology · doi:10.1097/00001622-200011000-00011 · Cited by 65
Mantovani, G., Macci�, A., Melis, G. B., Mura, L., Massa, E., & Mudu, M. C. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000615)86:6 · Cited by 51
Eosinophils infiltrating interleukin‐5 gene‐transfected tumors do not suppress tumor growth
Krüger‐Krasagakes, S., Li, W., Richter, G. H. S., Diamantstein, T., & Blankenstein, T. J. F. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230438 · Cited by 48
Ohashi, Y., Ishibashi, S., Suzuki, T., Shineha, R., Moriya, T., Satomi, S., & Sasano, H. (2000) · PubMed · Cited by 44
Canali, R., Vignolini, F., Nobili, F., & Mengheri, E. (2000) · Free Radical Biology & Medicine · doi:10.1016/s0891-5849(00)00285-9 · Cited by 44
A new method of antitumor therapy with a high dose of TNF perfusion for unresectable liver tumors.
Nakamoto, T., Inagawa, H., Takagi, K., & Soma, G. (2000) · PubMed · Cited by 40
Bussolati, B., Mariano, F., Cignetti, A., Guarini, A. R., CAMBI, V., Foà, R., Piccoli, G., & Camussi, G. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.3.1493 · Cited by 39
Activation of B lymphocytes by NK cells
Yuan, D., Wilder, J. A., Dang, T., Bennett, M., & Kumar, V. (1992) · International Immunology · doi:10.1093/intimm/4.12.1373 · Cited by 39
Evidence for IL-12-Activated Ca2+ and Tyrosine Signaling Pathways in Human Neutrophils
Collison, K. S., Saleh, S. M., Parhar, R. S., Meyer, B. C., Kwaasi, A. A. A., Al-Hussein, K., Al‐Sedairy, S. T., & Al-Mohanna, F. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3737 · Cited by 39
Antitumor and antimetastatic effects of interleukin 12
Fujiwara, H., & Hamaoka, T. (1996) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800051032 · Cited by 29
Cultured stromal cells: An in vitro model of prostatic mesenchymal biology
Peehl, D. M., & Sellers, R. G. (2000) · The Prostate · doi:10.1002/1097-0045(20001001)45:2 · Cited by 29
Lasek, W., Mackiewicz, A. A., Czajka, A., Świtaj, T., Gołąb, J., Wiznerowicz, M., Korczak-Kowalska, G., Bałkowiec-Iskra, E., Gryska, K., Iżycki, D., et al. (2000) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700263 · Cited by 29
Fujisawa, N., Hayashi, S., & Miller, E. J. (1999) · Melanoma Research · doi:10.1097/00008390-199904000-00001 · Cited by 27
Ye, J., Ding, M., Zhang, X., Rojanasakul, Y., & Shi, X. (2000) · PubMed · Cited by 27
Serum-Soluble IL-2 Receptor and IL-6 Levels in Patients with Melanoma
Boyano, M. D., García-Vázquez, M. D., Gardeazábal, J., de Galdeano, A. G., Zubiaga, I. S., Cañavate, M., Ratón, J. A., Bilbao, I., & Díaz-Pérez, J. L. (2009) · Oncology · doi:10.1159/000227726 · Cited by 23
Ju, D. W., Zheng, Q. Y., Cao, X., Fang, J., & Wang, H. (1998) · Pharmacology · doi:10.1159/000028197 · Cited by 22
Wakiyama, T., Shinohara, T., Shirakusa, T., As, J., & Tuszynski, G. P. (2001) · PubMed · doi:10.14670/hh-16.345 · Cited by 19
Limited Proteolysis of Angiogenin by Elastase Is Regulated by Plasminogen
Hu, G.-F. (1997) · Journal of Protein Chemistry · doi:10.1023/a:1026302419881 · Cited by 18
Joseph, I. B. J., & Isaacs, J. T. (1996) · The Prostate · doi:10.1002/(sici)1097-0045(199609)29:3 · Cited by 15
Yang, S., Vervaert, C. E., Seigler, H. F., & Darrow, T. L. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300820 · Cited by 15
Biological Implications of Growth Factors on the Mechanism of Invasion in Gynecological Tumor Cells
Ueda, M., Ueki, M., Terai, Y., Ueki, K., Kumagai, K., Fujii, H., Yoshizawa, K., & Nakajima, M. (1999) · Gynecologic and Obstetric Investigation · doi:10.1159/000010160 · Cited by 11
Antimetastatic effect of flurbiprofen and other platelet aggregation inhibitors.
Mamytbeková, A., Řežábek, K., Kacerovská, H., Grimová, J., & Svobodová, J. (1986) · PubMed · Cited by 11
Hwang, I., Nahm, D., Cho, S., Longenecker, B. M., Koganty, R. R., & Park, I. S. (1999) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320050320 · Cited by 5
Suppression of intestinal polyposis by inhibition of COX-2 in Apc knockout mice.
Vane, J. R. (1997) · PubMed · Cited by 5
Cowan (2001) · doi:10.1002/1097-0215(20010101)91:1
Flagged first, then by citations
1 of the 125 references couldn’t be matched to a known paper.
Research works printed but not linked: 4
- Rollins BJ. Chemokines. Blood 1997; 90: 909–28. · DOI
- Richard D, Berra E, Pouyssegur J. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J Biol Chem 2000; 275: 26765–71. · DOI
- Johnson W, Anderson K, Lazovich D et al. Association of aspirin and other NSAID use with incidence of postmenopausal breast cancer. In Proceedings of AACR, New Orleans 2001; 763.
- Cao Y, Prescott S. Fatty acid CoA-ligase 4 and cyclooxygenase 2 promote carcinogenesis by lowering the intracellular level of free arachidonic acid. In Proceedings of AACR, New Orleans 2001; 591.
Cited by
Sorted by citations
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1256 · Cited by 3,413
Cancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343
AACR Centennial Series: The Biology of Cancer Metastasis: Historical Perspective
Talmadge, J. E., & Fidler, I. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1040 · Cited by 1,242
Inflammation, a Key Event in Cancer Development
Lu, H., Ouyang, W., & Huang, C. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0261 · Cited by 1,049
Metadata
- Authors
- Brigati, C., Noonan, D. M., Albini, A., & Benelli, R.
- Corresponding author
- Brigati, Claudio
- Venue
- Clinical & Experimental Metastasis
- Published
- 2002-05
- Volume
- 19
- Issue
- 3
- Pages
- 247-258
- ISSN
- 0262-0898 (ISSN-L)
- 1573-7276
- OpenAlex
- W1550108534
- Cited by
- 230
- References
- 125
- Citations by year
- 2025: 2 · 2024: 5 · 2023: 3 · 2022: 9 · 2021: 8 · 2020: 5 · 2019: 6 · 2018: 5 · 2017: 10 · 2016: 10 · 2015: 11 · 2014: 6 · 2013: 10 · 2012: 19
- FWCI
- 0.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Clinical & Experimental Metastasis (publishedVersion)
- PubMed (publishedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion)
- IrInSubria (University of Insubria) (submittedVersion)
- Funders
- Compagnia di San Paolo
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Keywords
- tumor inflammation, inflammatory cell infiltration, tumor invasion, tumor microenvironment
- MeSH terms
- Humans, Inflammation, Models, Biological, Neoplasms, Prostaglandin-Endoperoxide Synthases, Transcription Factors, Cytokines, Receptors, Cytoplasmic and Nuclear, Chemokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review